MedTrace Logo

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

NCT00899613 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2009-12-15

No results posted yet for this study

Summary

RATIONALE: Studying levels of mesothelin and osteopontin in samples of blood from patients with mesothelioma or atypical mesothelial hyperplasia may help doctors identify biomarkers related to cancer.

PURPOSE: This research study is looking at mesothelin and osteopontin as diagnostic markers in patients with mesothelioma or atypical hyperplasia.

Conditions

Interventions

OTHER

laboratory biomarker analysis

PROCEDURE

study of high risk factors

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Francoise Galateau-Salle · University Hospital, Caen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2010-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899613 on ClinicalTrials.gov